US equities
|
NVDA
$233.95
▲+1.34%
MU
$1,074.89
▼-2.05%
TSLA
$370.59
▲+4.65%
SPCX
$158.96
▲+7.35%
SNDK
$1,719.99
▼-3.79%
AMD
$633.91
▲+2.95%
STX
$848.99
▼-10.21%
INTC
$119.33
▼-0.56%
NVDA
$233.95
▲+1.34%
MU
$1,074.89
▼-2.05%
TSLA
$370.59
▲+4.65%
SPCX
$158.96
▲+7.35%
SNDK
$1,719.99
▼-3.79%
AMD
$633.91
▲+2.95%
STX
$848.99
▼-10.21%
INTC
$119.33
▼-0.56%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Articles published by OptimizeRx Corporation
< Previous
1
2
Next >
OptimizeRx Brings Net New Authenticated HCP Reach to The Trade Desk Through OpenPath
September 22, 2026
From
OptimizeRx Corporation
Via
GlobeNewswire
Tickers
OPRX
OptimizeRx Expands Natural Language Audience Builder to Unify HCP and DTC Audience Intelligence
September 14, 2026
From
OptimizeRx Corporation
Via
GlobeNewswire
Tickers
OPRX
OptimizeRx to Participate in the 10th Annual Lake Street Best Ideas Growth Conference
September 08, 2026
From
OptimizeRx Corporation
Via
GlobeNewswire
Tickers
OPRX
OptimizeRx Appoints Pharma Commercialization and AI Expert Troy Sarich as Company Advisor
September 02, 2026
From
OptimizeRx Corporation
Via
GlobeNewswire
Tickers
OPRX
OptimizeRx Announces Finance Leadership Appointments to Support the Next Phase of Growth
August 12, 2026
From
OptimizeRx Corporation
Via
GlobeNewswire
Tickers
OPRX
OptimizeRx Reports Second Quarter 2026 Financial Results and Updates Fiscal Year 2026 Guidance
August 12, 2026
From
OptimizeRx Corporation
Via
GlobeNewswire
Tickers
OPRX
OptimizeRx Sets Second Quarter 2026 Conference Call for August 12, 2026, at 4:30 p.m. ET
July 29, 2026
From
OptimizeRx Corporation
Via
GlobeNewswire
Tickers
OPRX
OptimizeRx Appoints Veteran Point of Care Marketing Leader Sarah Bast as Chief Marketing Officer
July 23, 2026
From
OptimizeRx Corporation
Via
GlobeNewswire
Tickers
OPRX
OptimizeRx Launches CopayCue™, a Next-Generation Copay Activation Solution Powered by Real-Time Prescribing Intent
June 30, 2026
From
OptimizeRx Corporation
Via
GlobeNewswire
Tickers
OPRX
OptimizeRx Launches Natural Language Audience Builder for Life Sciences DSPs and Agency Media Planning Platforms
June 25, 2026
From
OptimizeRx Corporation
Via
GlobeNewswire
Tickers
OPRX
OptimizeRx to Participate in Upcoming Investor Conferences
June 01, 2026
From
OptimizeRx Corporation
Via
GlobeNewswire
Tickers
OPRX
DeepIntent Becomes First Healthcare DSP to Integrate OptimizeRx’s Authenticated EHR Network
May 21, 2026
From
OptimizeRx Corporation
Via
GlobeNewswire
Tickers
OPRX
OptimizeRx Reports First Quarter 2026 Financial Results and Updates Fiscal Year 2026 Guidance
May 12, 2026
From
OptimizeRx Corporation
Via
GlobeNewswire
Tickers
OPRX
OptimizeRx Launches Programmatic Access to Authenticated EHR Advertising at Scale
May 11, 2026
From
OptimizeRx Corporation
Via
GlobeNewswire
Tickers
OPRX
OptimizeRx Releases 2026 Environmental, Social, and Governance (ESG) Report
April 29, 2026
From
OptimizeRx Corporation
Via
GlobeNewswire
Tickers
OPRX
OptimizeRx Sets First Quarter 2026 Conference Call for May 12, 2026, at 4:30 p.m. ET
April 28, 2026
From
OptimizeRx Corporation
Via
GlobeNewswire
Tickers
OPRX
UPDATE – OptimizeRx Reports Strong Fourth Quarter and Full Year 2025 Financial Results
March 05, 2026
From
OptimizeRx Corporation
Via
GlobeNewswire
Tickers
OPRX
OptimizeRx Reports Strong Fourth Quarter and Full Year 2025 Financial Results
March 05, 2026
From
OptimizeRx Corporation
Via
GlobeNewswire
Tickers
OPRX
OptimizeRx Sets Fourth Quarter and Full Year 2025 Financial Results Conference Call for March 5, 2026, at 4:30 p.m. ET
February 05, 2026
From
OptimizeRx Corporation
Via
GlobeNewswire
Tickers
OPRX
OptimizeRx and Experian Collaborate to Improve Privacy-Safe Identity Resolution in Healthcare Marketing
January 07, 2026
From
OptimizeRx Corporation
Via
GlobeNewswire
Tickers
OPRX
OptimizeRx Continues Expansion of the Company’s Point-Of-Care Network
December 17, 2025
From
OptimizeRx Corporation
Via
GlobeNewswire
Tickers
OPRX
OptimizeRx Reports Third Quarter 2025 Financial Results and Increases Fiscal Year 2025 Guidance
November 06, 2025
From
OptimizeRx Corporation
Via
GlobeNewswire
Tickers
OPRX
OptimizeRx Sets Third Quarter 2025 Conference Call for November 6, 2025, at 4:30 p.m. ET
October 20, 2025
From
OptimizeRx Corporation
Via
GlobeNewswire
Tickers
OPRX
OptimizeRx to Participate in the 9th Annual Lake Street Capital Best Ideas Growth Conference
September 10, 2025
From
OptimizeRx Corporation
Via
GlobeNewswire
Tickers
OPRX
OptimizeRx Partners with Lamar Advertising to Reach Clinically Relevant Audiences Through Out-of-Home Healthcare Advertising
September 09, 2025
From
OptimizeRx Corporation
Via
GlobeNewswire
Tickers
LAMR
OPRX
OptimizeRx Corporation Announces Leadership Team Advancements to Accelerate Strategic Growth
August 19, 2025
From
OptimizeRx Corporation
Via
GlobeNewswire
Tickers
OPRX
OptimizeRx Reports Second Quarter 2025 Financial Results and Updates Fiscal Year 2025 Guidance
August 07, 2025
From
OptimizeRx Corporation
Via
GlobeNewswire
Tickers
OPRX
OptimizeRx Sets Second Quarter 2025 Conference Call for August 7, 2025, at 4:30 p.m. ET
July 17, 2025
From
OptimizeRx Corporation
Via
GlobeNewswire
Tickers
OPRX
OptimizeRx Corporation Appoints CEO Steve Silvestro to Board of Directors
June 24, 2025
From
OptimizeRx Corporation
Via
GlobeNewswire
Tickers
OPRX
OptimizeRx to Participate in Upcoming Investor Conferences
May 16, 2025
From
OptimizeRx Corporation
Via
GlobeNewswire
Tickers
OPRX
< Previous
1
2
Next >
